Quick Takeaways
- This page summarizes Christopher Downs's Form 4 filing for CNS Pharmaceuticals, Inc. (CNSP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 23 Aug 2023, 08:00.
Christopher Downs - 22 Aug 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)
- Signature
- /s/ Christopher Downs
- Issuer symbol
- CNSP
- Transactions as of
- 22 Aug 2023
- Net transactions value
- +$34,177
- Form type
- 4
- Filing time
- 23 Aug 2023, 08:00:04 UTC
- Previous filing
- 01 May 2023
- Next filing
- 06 Feb 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Christopher Downs filed Form 4 for CNS Pharmaceuticals, Inc. (CNSP) on 23 Aug 2023."
What Changed
- Previous filing in this sequence was filed on 01 May 2023.
- Current net transaction value: +$34,177.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
CNSP
transaction
Common Stock
Purchase
- Transaction value
- $34,177
- Shares
- +27,000
- Change %
- +276%
- Price
- $1.27
- Shares after
- 36,772
- Date
- 22 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $1.2196 to $1.2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |